Live Breaking News & Updates on Doug Salvador

Stay updated with breaking news from Doug salvador. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

COVID patients should weigh antibody therapy, though data on effectiveness is limited, doctor advises


COVID patients should weigh antibody therapy, though data on effectiveness is limited, doctor advises
Updated Jan 17, 2021;
Posted Jan 17, 2021
In this undated image from video provided by Regeneron Pharmaceuticals, scientists work with a bioreactor at a company facility in New York state, for efforts on an experimental coronavirus antibody drug. (Regeneron via AP)AP
Facebook Share
The U.S. government recently advised those with COVID-19 and at risk for serious complications to ask their health care provider about one of the monoclonal antibody therapies authorized by the U.S. Food and Drug Administration in November for emergency use.
The outpatient therapies, Eli Lilly’s bamlanivimab and Regeneron’s casirivimab and imdevimab (REGEN-COV2), contain laboratory-made antibodies designed to mimic the body’s immune system and block the virus that causes COVID-19 from infecting cells. President Donald Trump was given REGEN-COV2 when he tested positive in ....

United States , Bay State , Baystate Medical Center , Donald Trump , Eli Lilly , Baystate Health , Human Services Alex Azar , Beth Israel Deaconess Medical Center , Berkshire Health , Drug Administration , Medical Center , Chief Medical Officer , Doug Salvador , United States Secretary , Western Massachusetts , ஒன்றுபட்டது மாநிலங்களில் , வளைகுடா நிலை , பேஸ்டேட் மருத்துவ மையம் , டொனால்ட் துருப்பு , எலி லில்லி , பேஸ்டேட் ஆரோக்கியம் , மனிதன் சேவைகள் அலெக்ஸ் அசார் , பெத் இஸ்ரேல் டேப்ககோணேஸ் மருத்துவ மையம் , பெர்க்ஷயர் ஆரோக்கியம் , மருத்துவ மையம் , தலைமை மருத்துவ அதிகாரி ,